MAR 11, 2016 8:14 AM PST

Macrophages Break Down Protective Barrier of Pancreatic Tumors

WRITTEN BY: Kara Marker
In 2016, the five-year survival rate for pancreatic cancer increased from seven to eight percent (American Cancer Society). Not a monumental increase, but scientists are still working on therapies to get the numbers even higher.

Scientists from the Abramson Cancer Center University of Pennsylvania School of Medicine, in their new preclinical study published in the journal Cancer Discovery, investigated the potential of macrophages to break down protective walls around pancreatic tumors, also known as their microenvironment. They found that sending certain signals to macrophages with an experimental immune therapy can be successful in influencing them to strip away the protective parts that pancreatic tumors use to evade the harsh chemicals of chemotherapies.
 


“We’ve learned how antibodies that target a cell surface molecule called CD40 work with the immune system to tear back that wall,” said study leader Gregory Beatty, MD, PhD. Plus, the same antibodies were found to actually enhance the effect of chemotherapy once the tumor’s defenses were stripped away.

The ACC study recently published followed a previous study by the same researchers. In 2011 they illustrated the ability of CD40 to prompt monocyte and macrophage populations to destruct the tumor microenvironment. However, until their newest study, the team couldn’t pinpoint the precise mechanism behind the connection between CD40 and the immune cells.

Their new study involved mouse models of pancreatic cancer, and they were able to identify two immune factors released after CD40 antibody treatment. The suspects are chemokine ligand 2 (CCL2) and interferon gamma. While CCL2 recruits macrophage tumor infiltration, interferon-gamma prompts macrophages to release enzymes called metalloproteinases, which degrade the “fibrotic scaffold” of the tumor microenvironment, the structure that protects the cancerous cells from destruction by chemotherapy.

The tag team effort of CCL2 and interferon-gamma, as a result of CD40 antibody stimulation, leads to fibrosis degradation, identified by the scientists as the final blow in breaking down the tumor defenses.

While this discovery is promising in the fight against pancreatic cancer, the research team also realized that the timing of CD40 treatment followed by chemotherapy is extremely critical: too soon and patients are at risk for a 30 percent mortality rate, and too late and the chemotherapy is ineffective. They found that the “sweet spot” for chemotherapy delivery is five days post-CD40 treatment, where they saw the treatment well-tolerated and tumor cells shrinking and dying.

“Macrophages can be very potent killers of cancer,” Beatty said. “Since keeping them out of tumors is a challenge, why not harness their recruitment?”
 

Source: University of Pennsylvania School of Medicine
 
About the Author
I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
SEP 04, 2022
Microbiology
Sugar Disrupts the Microbiome, Altering Immunity
SEP 04, 2022
Sugar Disrupts the Microbiome, Altering Immunity
The microbes in our gut are indispensable to our health, and they are affected by what we eat. New research has used a m ...
SEP 09, 2022
Immunology
Antibodies are Sometimes Made with 'Stolen' DNA
SEP 09, 2022
Antibodies are Sometimes Made with 'Stolen' DNA
The human immune system must respond to a diverse array of infectious agents and harmful invaders throughout our lifetim ...
OCT 18, 2022
Immunology
T Cell Deficiency Leaves Some Vulnerable to Infection
OCT 18, 2022
T Cell Deficiency Leaves Some Vulnerable to Infection
The mycobacterium avium complex (MAC) bacteria can be found everywhere, so almost everyone breathes some of it in occasi ...
NOV 03, 2022
Immunology
A Dietary Fiber Can Affect the Microbiome & Trigger Inflammation
NOV 03, 2022
A Dietary Fiber Can Affect the Microbiome & Trigger Inflammation
Inulin is one type of fiber that we consume in our diets, and can be found in fruits, vegetables, and grains including w ...
NOV 03, 2022
Drug Discovery & Development
A new vaccine against RSV can protect children from the virus immediately at birth
NOV 03, 2022
A new vaccine against RSV can protect children from the virus immediately at birth
As COVID-19 and flu virus infection rates are on the rise, another virus is now wreaking havoc on the United States ...
NOV 28, 2022
Microbiology
A Vaccine to Prevent Urinary Tract Infections is in Development
NOV 28, 2022
A Vaccine to Prevent Urinary Tract Infections is in Development
New research has shown that a vaccine for the bacteria commonly associated with urinary tract infections works in animal ...
Loading Comments...